Sperogenx Biosciences Private Limited - Due diligence report

A 360° intelligence report on Sperogenx Biosciences Private Limited: trust score, financial health, credit view, compliance, directors, grow…

2018-05-23 Bangalore, Karnataka Active Unlisted
Share
View plans Plan
SB Sperogenx Biosciences Private Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sperogenx Biosciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
85/100
Trust Score
Low Risk

Sperogenx Biosciences Private Limited is assessed as Low Risk with a Trust Score of 85/100. Sperogenx Biosciences Private Limited is an active private limited indian non-government company incorporated in 2018, operating in the Internet sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 14 Jul 2026 from the latest processed filings. Sperogenx Biosciences Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
85/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Elevated gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (10.00 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Bank Of India1 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MANI VIGNESHWARAN 01234567 Director 01/04/2018 6 yrs Approved
ARUN SURENDRAN 01234567 Director 01/04/2018 6 yrs Approved
SAURABH GARG 01234567 Director 01/04/2018 6 yrs Approved
CHINNASAMY THIRUPPATHIRAJA 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 3 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: CHINNASAMY THIRUPPATHIRAJA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 90
Growth signals & trust indicators
Profit expanded 1.42 year-on-year.
Asset base grew 2.1x - capacity expansion.
Net margin improved to 24%.
Operating for 8 years.
Active GST registration(s).
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 10.00 Lakh already registered.
  • Compliance record supports lending.
Investor view76/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
13 May 2022
Director ceased
RATUL BANERJEE
25 Feb 2022
Director ceased
SACHIN GOTAKINDI
07 Sep 2021
Charge created
Bank Of India - 10.00 Lakh
10 Apr 2021
Director appointed
MANI VIGNESHWARAN (Additional Director)
Director ceased
MANI MAHENDRAN
31 Mar 2021
Share transfer (FY 2021)
2500.00000000 shares to VIGNESHWARAN MAHENDRAN
30 Sep 2019
Director ceased
ARUN SURENDRAN
Director ceased
SAURABH GARG
31 Mar 2019
Share transfer (FY 2019)
500.00000000 shares to SURENDRAN ARUN
Share transfer (FY 2019)
500.00000000 shares to BANERJEE RATUL
21 Feb 2019
Director appointed
ARUN SURENDRAN (Director)
Director appointed
SAURABH GARG (Director)
14 Jul 2018
Securities allotted
4000 Equity Shares - 4.00 Lakh raised
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 0.86 - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Prowess Healthcare Services India Private Limited U85310TG2017PTC115408 Hyderabad, Telangana, India
Dynamicro Labs Private Limited U33125MH1999PTC120985 Dombivli, Maharashtra, India
Nucleosome Wellness Private Limited U85100WB2020PTC238270 Siliguri, West Bengal, India
Medseed Chemist Private Limited U24299PN2021PTC205833 Kolhapur, Maharashtra, India
Teeliv Healthcare India Private Limited U33111MH2013PTC240228 Mumbai, Maharashtra, India
Dart Seva Healthline Services Private Limited U85100KA2015PTC083106 Bangalore, Karnataka, India
Gravity Global Hospitality Private Limited U70200DL2017PTC323088 New Delhi, Delhi, India
Urvi & Peeyush Private Limited U93090HR2018PTC076384 Rewari, Haryana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sperogenx Biosciences Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sperogenx Biosciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Sperogenx Biosciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether Sperogenx Biosciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Sperogenx Biosciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sperogenx Biosciences Private Limited an active company?

Sperogenx Biosciences Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Sperogenx Biosciences Private Limited financially healthy?

Sperogenx Biosciences Private Limited has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Sperogenx Biosciences Private Limited?

Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sperogenx Biosciences Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Sperogenx Biosciences Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Sperogenx Biosciences Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Sperogenx Biosciences Private Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.